ITIH3 | Inter-alpha-trypsin inhibitor heavy chain 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RTP3 | Receptor (chemosensory) transporter protein 3 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A25 | Solute carrier family 22, member 25 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LECT2 | Leukocyte cell-derived chemotaxin 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SDS | Serine dehydratase | Enzymes Plasma proteins
| | | | | Tissue enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
VTN | Vitronectin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enriched |
GOLGA6B | Golgin A6 family, member B | | | | | | Group enriched |
PGLYRP2 | Peptidoglycan recognition protein 2 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
INHBE | Inhibin, beta E | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
UGT2A2 | UDP glucuronosyltransferase 2 family, polypeptide A2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CYP2B6 | Cytochrome P450, family 2, subfamily B, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
HSD17B13 | Hydroxysteroid (17-beta) dehydrogenase 13 | | | | | | Tissue enriched |
MAT1A | Methionine adenosyltransferase I, alpha | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CPB2 | Carboxypeptidase B2 (plasma) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANG | Angiogenin, ribonuclease, RNase A family, 5 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP26A1 | Cytochrome P450, family 26, subfamily A, polypeptide 1 | | | | | | Tissue enriched |
GC | Group-specific component (vitamin D binding protein) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AC137056.1 | Uncharacterized protein; cDNA FLJ34659 fis, clone KIDNE2018863 | Predicted secreted proteins
| | | | | Group enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | | | | Tissue enriched |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GYS2 | Glycogen synthase 2 (liver) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
C5 | Complement component 5 | Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ITIH4 | Inter-alpha-trypsin inhibitor heavy chain family, member 4 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ASGR1 | Asialoglycoprotein receptor 1 | | | | | | Tissue enriched |
CYP8B1 | Cytochrome P450, family 8, subfamily B, polypeptide 1 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |